Most Recent
Novartis can’t appeal loss of experts in MS drug patent feud with Pharmacor
The Full Federal Court won't give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.
Full Court ruling on MIS regime may not resolve funding issues in RFG class action, court hears
A case before the Full Court that will revisit the question of whether class actions are managed investment schemes may not resolve all of the funding controversies that have emerged in a class action against franchise giant Retail Food Group, a court has heard.
Full Court ‘compelled’ to find class closure judgment ‘plainly wrong’
The Full Federal Court has found that a landmark NSW Court of Appeal decision barring group members from being notified of future class closure orders at settlement was "plainly wrong" and that the court has the power to make the orders.
JD Group wins stay of damages for couple ‘misled’ over $10M luxury digs
Damages owed to a millionaire couple by JD Group over a "deliberately misleading" rendering of a $9.58 million apartment in South Yarra, Melbourne will be put on ice pending the outcome of the property developer's appeal.
ACCC says agreement to settle Revlimid patent suit could violate cartel laws
The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to invalidate the patents for its blockbuster cancer drug Revlimid, saying it could distort competition between generic drug makers.
Court appoints contradictor in class action funder’s challenge to MIS rules
The Full Federal Court has appointed a contradictor to "take up the cudgels" against funder Litigation Capital Management, which has challenged a judgment refusing to find that a class action filed against Queensland electricity operators was not a managed investment scheme.
ASIC seeks recusal of former Freehills lawyer in costs spat with ex-Tennis Australia boss
ASIC has asked a Federal Court registrar who previously worked at Herbert Smith Freehills to step down from overseeing remaining costs disputes in its failed case against former Tennis Australia president Steven Healy, who is represented by the Big Six firm.
Full Court deals drug companies a blow on patent term extensions
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a "commercial outcome for a patentee".
No duty of care owed to kids by environment minister, Full Court rules
The Full Federal Court has overturned a historic judgment that found the federal minister for the environment owed a duty of care to Australians under 18 to protect them from 'catastrophic' harm caused by the approval of the Vickery coal mine expansion.
ANZ denies charging retrospective interest on credit cards
ANZ has hit back at claims in a class action that it slugged retrospective interest on credit card accounts and that its interest terms were not explicit, arguing the term 'retrospective' is liable to "confuse" the issues to be decided by the court.